-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Anavex Life Sciences Corp. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Anavex Life Sciences Corp. Operating Income (Loss) for the quarter ending June 30, 2024 was -$14.7M, a 8.85% decline year-over-year.
- Anavex Life Sciences Corp. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$51.2M, a 12.3% increase year-over-year.
- Anavex Life Sciences Corp. annual Operating Income (Loss) for 2023 was -$55.8M, a 9.36% decline from 2022.
- Anavex Life Sciences Corp. annual Operating Income (Loss) for 2022 was -$51M, a 21.4% decline from 2021.
- Anavex Life Sciences Corp. annual Operating Income (Loss) for 2021 was -$42M, a 35.1% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)